Location: Baltimore
Synced from ClinicalTrials.gov · July 28, 2026
Clinical studies recruiting near Baltimore
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
Pediatric Neuroimaging
Phase N/A · National Institute of Aging, Clinical Research Unit · National Institute on Aging (NIA) · NCT06912724To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
Phase 3 · Maryland Locations Biomed Testing Facility #BIO-9-21205 · Biomed Industries, Inc. · NCT06840496The PREDICT Registry:
Phase N/A · MedStar Health Research Institute · PreludeDx · NCT03448926Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
Phase 1 · ADP Investigational Site · USWM CT, LLC · NCT03391778Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Speci
Phase 3 · University of Maryland Medical Center · Corvus Pharmaceuticals, Inc. · NCT06561048Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support
Phase N/A · Johns Hopkins Hospital · Johns Hopkins University · NCT06840210Lumbosacral Spinal Stenosis - Non-Invasive Postural Therapy for Older Adult Veterans
NA · Baltimore VA Medical Center VA Maryland Health Care System, · VA Office of Research and Development · NCT06089746TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidos
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07223203A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With
Phase 3 · Research Site · AstraZeneca · NCT06023589Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Phase 2 · Johns Hopkins University · Johns Hopkins University · NCT07059091Neoadjuvant Darovasertib in Primary Uveal Melanoma
Phase 3 · Wilmer Eye Institute · IDEAYA Biosciences · NCT07015190Feasibility Study for Fibroblast Autologous Skin Grafts
Phase 2 · Johns Hopkins School of Medicine, Dermatology Department · Johns Hopkins University · NCT01964859Hyperbaric Oxygen Brain Injury Treatment Trial
Phase 2 · University of Maryland · Gaylan Rockswold · NCT02407028A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodyst
Phase 3 · Kennedy Krieger Institute · Minoryx Therapeutics, S.L. · NCT05819866Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
Phase N/A · Wilmer Eye Institute at John Hopkins · Ascidian Therapeutics, Inc · NCT06445322Personalized Treatment in Thyroid Disorders
NA · Johns Hopkins Hospital · Johns Hopkins University · NCT03517579Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · University of Maryland/Greenebaum Cancer Center · National Cancer Institute (NCI) · NCT05987241Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
Phase 3 · University of Maryland · NX Development Corp · NCT05804370Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · Sinai Hospital of Baltimore, Inc. · Gilead Sciences · NCT05633654High-resolution Phosphocreatine and Creatine Mapping of Human Muscle and Brain
Phase N/A · F. M. Kirby Center and Johns Hopkins University Medical Scho · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · NCT04234880A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Phase 1/Phase 2 · Sidney Kimmel Comprehensive Cancer Center at John Hopkins · Phanes Therapeutics · NCT05652686A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin)
Phase 1/Phase 2 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Eisai Inc. · NCT04300556MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · MedStar Union Memorial Hospital · Stryker Instruments · NCT03072927A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Canc
Phase 3 · University of Maryland · Janssen Research & Development, LLC · NCT07225946Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
Phase 3 · Elman Retina Group, P.A. · Jaeb Center for Health Research · NCT06790784Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Particip
Phase 1/Phase 2 · University of Maryland-Greenebaum Comprehensive Cancer Cente · Merck Sharp & Dohme LLC · NCT06353386Vestibular Implantation to Treat Adult-Onset Bilateral Vestibular Hypofunction
NA · Johns Hopkins School of Medicine · Johns Hopkins University · NCT05674786Incorporation of Safe Sleep Education Into m-Health Technology
NA · Johns Hopkins School of Medicine · Johns Hopkins University · NCT06074211Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With G
Phase 2/Phase 3 · University of Maryland/Greenebaum Cancer Center · ECOG-ACRIN Cancer Research Group · NCT07001748Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
NA · Johns Hopkins Children's Center · Children's Hospital of Philadelphia · NCT05975671
Look up another city
Look up another condition